SANTA CLARA, Calif. / Dec 18, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that CEO Mike McMullen and CFO Bob McMahon will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 9, 2024, at 9:45 a.m. Pacific Time.
A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.
| Last Trade: | US$107.45 |
| Daily Change: | -28.66 -21.06 |
| Daily Volume: | 281,128 |
| Market Cap: | US$30.690B |
April 24, 2025 March 20, 2025 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
